Inno-Gene to move to WSE main market

Poland's biotechnology company Inno-Gene maintains its plan to move from the NewConnect alternative market to the Warsaw Stock Exchange main trading floor in H1 2016, the company informed. "In the third quarter we devoted much attention to the preparation and the conduct of the issue. This allowed us to raise PLN 4 million, which meets the capital needs of Inno-Gene in the medium term," said CEO, Jacek Wojciechowicz, in a press release. Inno-Gene has been supporting and commercializing innovative biotechnology projects, for instance it is going to offer NIPT - Non-Invasive Prenatal Testing.